Ribometrix

Ribometrix is a biotechnology company developing small molecule therapeutics that directly target RNA to treat human diseases. The Ribometrix team leverages its world-leading expertise in 3D structural analysis of RNA to drive its discovery platform, drawing on technologies invented in the laboratory of Ribometrix scientific founder Kevin Weeks, Ph.D.

Ribometrix

Durham, NC

Website

11.13.2018
Ribometrix Announces $30 Million Series A Funding to Advance Pipe…

Read More